Articles by Daniel Marsh
Pfizer Stock Dips 1.9% but Dividend Adjusts Decline
Pfizer ended Friday at $24.54, down 1.9% unadjusted, but dividend-adjusted returns fell just 0.16%. The FDA's priority review for Talzenna offers a key catalyst for Q4.
Opendoor Stock Plunges 15% as Mortgage Rates Hit 11-Month High
Opendoor shares fell nearly 15% in a week as mortgage rates hit 6.58%, the highest since August 2025, stoking fears of slower home sales and extended inventory.
Nuburu Shares Plunge 39% on Dilution Fears from Preferred Stock
Nuburu shares dropped 39% after concerns over dilution from a $73.4 million preferred stock issuance, which dwarfs its $16.3 million common equity market cap.
Paramount Skydance Faces $1.7 Billion Ticking Fee as Merger Delay Looms
Paramount Skydance faces a $1.7 billion ticking fee as court delays its Warner Bros Discovery merger, representing 18.5% of market cap.
Rotork Shares Flat as ABB Deal Spread Suggests Tight Timing for Completion
Rotork shares ended the week at 488p, leaving a 15p gap to ABB's 503p cash offer. The 3.1% spread indicates timing, not risk, is the key variable.
Vivakor Shares Jump 37% on $1.09B Crude Platform; Q1 Margin at 7.8 bps
Vivakor shares surged 37.3% to $2.91 after unveiling a $1.09 billion crude platform. Q1 supply-and-trading gross margin of 0.078% underscores thin profitability.
SK Hynix ADR Premium Widens to 28% as $750 Billion Supply Deal Looms
SK Hynix ADRs ended Friday 28% above parity with Seoul shares, driven by a massive $750 billion supply deal with U.S. tech companies. Earnings due Wednesday.